Updates are available Correction dated 2023-11-28
Click to view Correction: https://doi.org/10.1007/s00380-023-02337-7
-
Authors
Suzuki, Shinya http://orcid.org/0000-0002-4769-5925
Morishima, Yoshiyuki
Takita, Atsushi
Yagi, Naoharu
Otsuka, Takayuki
Arita, Takuto
Yamashita, Takeshi
-
Funding
Funding for this research was provided by:
Daiichi-Sankyo (Research funding)
- License Information
-
More Information
Article History
Received: 28 February 2019
Accepted: 17 May 2019
First Online: 23 May 2019
Change Date: 28 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00380-023-02337-7
Compliance with ethical standards
:
: This work was financially supported by Daiichi Sankyo. Dr. Suzuki received research funding from Daiichi Sankyo and Mitsubishi-Tanabe. Dr. Yamashita received research funding from Boehringer Ingelheim and Daiichi Sankyo, and remuneration from Boehringer Ingelheim, Daiichi Sankyo, Bayer Healthcare, Pfizer, Bristol-Myers Squibb, Eisai and Ono Pharmaceutical. Dr. Morishima and Mr. Takita are employees of Daiichi Sankyo. The management of this work was supported by Cardiovascular Institute Academic Research Organization (CVI ARO) [CitationRef removed–CitationRef removed].
